← FDA DEVICE PRODUCT CODES

FDA PRODUCT CODE · CLASS II

QVPSars-Cov-2 Serology Test

A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.

DEVICE CLASS
Class II
REGULATION
21 CFR 866.3983
MEDICAL SPECIALTY
Microbiology
REVIEW PANEL
MI
ImplantLife-sustainingGMP-exemptThird-party review eligible
3
510(K)/PMA CLEARANCES
510k: 3
0
RECALL ENTRIES

Recent clearances

K252280Roche Diagnostics · 510k2026-04-13
K253839Roche Diagnostics · 510k2025-12-17
K250768Roche Diagnostics · 510k2025-06-10

Related on SPEQ

Medical devices industryMedical device quality (ISO 13485)FDA device clearancesFDA enforcement & recalls

Source: FDA device classification, 510(k)/PMA, and recall datasets (openFDA). Recall entries count distinct FDA recall numbers, so one recall event affecting several products appears as several entries. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →